← Back to Search

Device

Intra-arterial Perfusion in Interventional Radiology

Palo Alto, CA
N/A
Waitlist Available
Led By Rajesh P Shah, MD
Research Sponsored by Palo Alto Veterans Institute for Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day to 1 year
Awards & highlights
No Placebo-Only Group

Summary

Patients are being asked to participate in a study to better determine blood flow going to tumors in the liver. They will undergo an embolization procedure in interventional radiology where the goal is to provide treatment directly into the liver tumor. These treatments are delivered into the blood vessels feeding the tumors. Improving these treatments relies on better understanding the blood flow into the tumor. By understanding how much blood flows into the tumors, the goal is to make sure there is the best chance of killing the tumor. The investigators are attempting to use a special type of CT scan during the procedure to determine the blood flow to the tumors.

See full description
Eligible Conditions
  • Liver Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Perfusion (procedure)
Secondary study objectives
Impact of low dose radiation technique on intra-arterial perfusion parameters

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard Dose Intra-arterial PerfusionExperimental Treatment1 Intervention
All patients will undergo standard of care interventional treatment for liver cancer. The procedure will take place utilizing fluoroscopic and CT guidance. During their procedure, patients will have intra-arterial CT perfusion maps derived of the liver including the region of the tumor. (n=10)
Group II: Low Dose Intra-arterial PerfusionExperimental Treatment1 Intervention
Investigate the impacts on contrast and radiation doses and the robustness of reconstruction algorithms on intra-arterial CT perfusion using a lower radiation dose technique. (N=10)

Find a Location

Closest Location:VA Palo Alto Health Care System· Palo Alto, CA· 2106 miles
Image of VA Palo Alto Health Care System in Palo Alto, United States.Image of VA Palo Alto Health Care System in Palo Alto, United States.Image of VA Palo Alto Health Care System in Palo Alto, United States.

Who is running the clinical trial?

Palo Alto Veterans Institute for ResearchLead Sponsor
56 Previous Clinical Trials
8,606 Total Patients Enrolled
Canon Medical Systems, USAIndustry Sponsor
13 Previous Clinical Trials
1,264 Total Patients Enrolled
Rajesh P Shah, MDPrincipal InvestigatorVA Palo Alto Health Care System - Interventional Radiology
~6 spots leftby Dec 2025